Literature DB >> 20568815

Proteomic analysis of interstitial fluid in bone marrow identified that peroxiredoxin 2 regulates H(2)O(2) level of bone marrow during aging.

Wei Wang1, Lantu Gou, Gang Xie, Aiping Tong, Fei He, Zejun Lu, Yuqin Yao, Kang Liu, Jie Li, Minghai Tang, Lijuan Chen, Jinliang Yang, Huozhen Hu, Yu-Quan Wei.   

Abstract

Hematopoiesis in bone marrow declines during aging owing to alteration of the hematopoietic niche. However, due to difficult accessibility and other complexities, senescence-related alteration of the hematopoietic niche is largely unknown. The interstitial fluid of bone marrow (IFBM), a pivotal component of the hematopoietic niche, includes soluble secretory factors that are present between bone marrow cells. To characterize the proteomic profile changes of IFBM during aging, we analyzed the IFBMs of young, adult, and senescent rats using 2-DE combined with ESI/MALDI-Q-TOF MS. Finally, 31 differentially expressed proteins involved in multiple biological functions were identified. Peroxiredoxin 2 (Prx2), down-regulated during aging, was further analyzed and demonstrated that it is produced by bone marrow stromal cells. Interestingly, higher levels of hydrogen peroxide (H(2)O(2)) were detected in the bone marrow with lower Prx2 expression. Moreover, exogenous Prx2 reduced the intracellular H(2)O(2) level in bone marrow stromal cells in vitro. Therefore, Prx2 is implied in the regulation of H(2)O(2) production in the bone marrow during aging. Our data characterized the dynamic protein profiles of the bone marrow microenvironment during aging and we provided clues to elucidate the mechanism of creating a low ROS level in the hematopoietic niche.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568815     DOI: 10.1021/pr901180w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution.

Authors:  Ningfei An; Michael G Janech; Alison M Bland; John Lazarchick; John M Arthur; Yubin Kang
Journal:  Exp Hematol       Date:  2013-08-27       Impact factor: 3.084

Review 2.  Oxidative stress response and Nrf2 signaling in aging.

Authors:  Hongqiao Zhang; Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2015-06-09       Impact factor: 7.376

3.  Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer.

Authors:  Bo Zhang; Kai Wang; Gang He; Xinying Guan; Botao Liu; Yangbo Liu; Yun Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

Review 4.  Changes in primary lymphoid organs with aging.

Authors:  Ivan K Chinn; Clare C Blackburn; Nancy R Manley; Gregory D Sempowski
Journal:  Semin Immunol       Date:  2012-05-02       Impact factor: 11.130

Review 5.  Strategies to retain properties of bone marrow-derived mesenchymal stem cells ex vivo.

Authors:  Yaxian Zhou; Tsung-Lin Tsai; Wan-Ju Li
Journal:  Ann N Y Acad Sci       Date:  2017-10-06       Impact factor: 5.691

Review 6.  Redox regulation of stem/progenitor cells and bone marrow niche.

Authors:  Norifumi Urao; Masuko Ushio-Fukai
Journal:  Free Radic Biol Med       Date:  2012-10-17       Impact factor: 7.376

Review 7.  Dynamic niches in the origination and differentiation of haematopoietic stem cells.

Authors:  Leo D Wang; Amy J Wagers
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-02       Impact factor: 94.444

8.  Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.

Authors:  Tetsuro Ishii; Eiji Warabi; Toru Yanagawa
Journal:  J Clin Biochem Nutr       Date:  2012-02-18       Impact factor: 3.114

Review 9.  ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation.

Authors:  S Chen; Y Su; J Wang
Journal:  Cell Death Dis       Date:  2013-07-11       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.